Optimal strategy of systemic treatment for unresectable pancreatic neuroendocrine tumors based upon opinion of Japanese experts: Optimal strategy of systemic treatment for unresectable PanNETs

Masafumi Ikeda, Chigusa Morizane, Susumu Hijioka, Shigemi Matsumoto, Tsuyoshi Konishi, Izumi Komoto, Taku Aoki, Tetsuhide Ito, Junji Furuse, Hironobu Sasano, Ryuichiro Doi

Research output: Contribution to journalArticle

Abstract

Background/objectives: A number of therapeutic agents have been reported to be clinically useful for the management of the patients with unresectable pancreatic neuroendocrine tumors (PanNETs) including somatostatin analogues, molecular-targeted agents and cytotoxic agents. However, the optimal strategy for selection among those treatment modalities above in these patients has remained unexplored. Methods: Japanese experts for PanNET discussed and determined the optimal treatment strategies according to the results of previously reported studies. Results: The tumor volume of liver metastases and the Ki-67 labeling index were unanimously accepted as indicators of the tumor burden and tumor aggressiveness, respectively, which are two most clinically pivotal factors for determining the strategy of systemic treatment for unresectable PanNETs. In addition, for those with a relatively small tumor burden and slow disease progression, somatostatin analogues were selected as the first-line treatment agents. For those with a relatively large tumor burden and rapid tumor progression, cytotoxic agents were selected, possibly aiming at tumor shrinkage. For those of intermediate tumor volume and/or growth rate, molecular-targeted agents were selected as the first choice. Based on this strategy discussed among the experts, we tentatively prepared a MAP for proposing optimal treatment strategy and examined its validity in some patients with unresectable PanNETs. Results validated the usefulness of this MAP proposed for patients harbouring unresectable PanNETs. Conclusion: We herein propose a tentative MAP for optimal treatment selection for the patients harbouring unresectable PanNETs. Further large scale studies are, however, warranted to validate the usefulness of this MAP proposed in this study.

Original languageEnglish
Pages (from-to)944-950
Number of pages7
JournalPancreatology
Volume20
Issue number5
DOIs
Publication statusPublished - 2020 Jul

Keywords

  • Cytotoxic agent
  • Molecular-targeted agent
  • PanNET
  • Somatostatin analogue
  • Treatment strategy

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Optimal strategy of systemic treatment for unresectable pancreatic neuroendocrine tumors based upon opinion of Japanese experts: Optimal strategy of systemic treatment for unresectable PanNETs'. Together they form a unique fingerprint.

  • Cite this